fOCUS Pharmaceuticals is a generic and branded dermatology pharmaceutical development company offering a new focus on pharmaceutical development for diseases and medical conditions of the skin.

 
 

 

Jur T. Strobos

Dr. Strobos is Of Counsel at Olsson, Frank and Weeda, P.C. He was born in New York, New York, and received his B.A. cum laude, in 1974 from John Hopkins University, his M.D. from University of Chicago in 1974, and his JD from University of Pennsylvania in 1987. Dr. Strobos received licenses to practice medicine in New York (1979), West Virginia (1980), Pennsylvania (1981), Maryland (1983), Delaware (1989), and District of Columbia (1989), and was a Fellow to the American College of Emergency Physicians, 1986-1996. He was admitted to the Pennsylvania, District of Columbia, and U.S. Patent Bars in 1988 and the California Bar in 1989.  After medical school, medical practice, law school, and a federal court clerkship, Dr. Strobos received an appointment in the U.S. Food and Drug Administration. He worked closely with then FDA Commissioner David A. Kessler on regulatory policy issues relating to drugs, devices, foods, human tissues and biological products as the Director of the Policy Research Staff/Office of Policy in the Commissioner's Office. His current practice concentrates on food, dietary supplement, medical device, medical product manufacturing and drug law, with a focus on regulatory applications and development and design of clinical studies, health insurance reimbursement, and product development strategy.

Laura S. Tanner

Dr. Tanner is a board certified dermatologist in private practice in Wilmington, NC. She did her undergraduate work at Millikin University where she graduated summa cum laude with a bachelor of science degree. Her master of science degree was completed at the University of Illinois at Chicago. The focus of her thesis was the molecular biology of keratin protein. She then attended Rush Medical College. While in medical school Dr. Tanner did research in the immunology of graft versus host disease. Both her internship and residency were done at the University of Arkansas for Medical Sciences. Dr. Tanner divides her private practice time between doing patient care, teaching medical students and residents, and doing research for major pharmaceutical companies.

Richard R. Dolighan

Richard Dolighan has over thirty years experience in the pharmaceutical industry. A native of Canada he began his career as a sales representative with Burroughs Wellcome and progressed to sales management. Holding senior management positions since 1979, his career has taken him to numerous locations in Canada, the United States and Puerto Rico. He has held the positions of Director of Sales and Marketing for Bristol Myers-Canada, President and General Manager Of Bristol Myers- Puerto Rico & The Caribbean, President and General Manager of Squibb-Canada, Group Vice President and General Manager of ICN Pharmaceuticals for North America and finally President and General Manager of the world-wide Radio- pharmaceutical business for the Dupont/Merck joint venture. He has directed numerous product introductions and provided key strategic direction and focus for sales and profit growth throughout his career. Mr. Dolighan is now retired and resides in the countryside outside of Toronto, Canada and still avails himself for selected consulting and advisory roles to industry.